ype Elgersma

Affiliations: 
Erasmus Medical Center Rotterdam, Rotterdam, Netherlands 
Area:
learning and memory
Google:
"ype Elgersma"
Mean distance: 14.27 (cluster 6)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rotaru DC, Mientjes EJ, Elgersma Y. (2020) Angelman Syndrome: From Mouse Models to Therapy. Neuroscience
Ottenhoff MJ, Krab LC, Elgersma Y. (2020) Considerations for clinical therapeutic development of statins for neurodevelopmental disorders. Eneuro
Ottenhoff MJ, Rietman AB, Mous SE, et al. (2020) Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1. Genetics in Medicine : Official Journal of the American College of Medical Genetics
Tonazzini I, Van Woerden GM, Masciullo C, et al. (2019) The role of ubiquitin ligase E3A in polarized contact guidance and rescue strategies in UBE3A-deficient hippocampal neurons. Molecular Autism. 10: 41
Bindels-de Heus KGCB, Mous SE, Ten Hooven-Radstaake M, et al. (2019) An overview of health issues and development in a large clinical cohort of children with Angelman syndrome. American Journal of Medical Genetics. Part A
Heimer G, van Woerden GM, Barel O, et al. (2019) Netrin-G2 dysfunction causes a Rett-like phenotype with areflexia. Human Mutation
Koene LMC, van Grondelle SE, Proietti Onori M, et al. (2019) Effects of antiepileptic drugs in a new TSC/mTOR-dependent epilepsy mouse model. Annals of Clinical and Translational Neurology. 6: 1273-1291
Avagliano Trezza R, Sonzogni M, Bossuyt SNV, et al. (2019) Loss of nuclear UBE3A causes electrophysiological and behavioral deficits in mice and is associated with Angelman syndrome. Nature Neuroscience
Overwater IE, Rietman AB, Mous SE, et al. (2019) A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex. Neurology
Sonzogni M, Hakonen J, Bernabé Kleijn M, et al. (2019) Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes. Molecular Autism. 10: 23
See more...